PROTEIN STRUCTURE AND FOLDING
Domain One of the High Affinity IgE Receptor, FcεRI, Regulates Binding to IgE through Its Interface with Domain Two*

https://doi.org/10.1074/jbc.275.13.9664Get rights and content
Under a Creative Commons license
open access

The high affinity receptor for IgE, FcεRI, binds IgE through the second Ig-like domain of the α subunit. The role of the first Ig-like domain is not well understood, but it is required for optimal binding of IgE to FcεRI, either through a minor contact interaction or in a supporting structural capacity. The results reported here demonstrate that domain one of FcεRI plays a major structural role supporting the presentation of the ligand-binding site, by interactions generated within the interdomain interface. Analysis of a series of chimeric receptors and point mutants indicated that specific residues within the A′ strand of domain one are crucial to the maintenance of the interdomain interface, and IgE binding. Mutation of the Arg15 and Phe17 residues caused loss in ligand binding, and utilizing a homology model of FcεRI-α based on the solved structure of FcγRIIa, it appears likely that this decrease is brought about by collapse of the interface and consequently the IgE-binding site. In addition discrepancies in results of previous studies using chimeric IgE receptors comprising FcεRIα with either FcγRIIa or FcγRIIIA can be explained by the presence or absence of Arg15 and its influence on the IgE-binding site. The data presented here suggest that the second domain of FcεRI-α is the only domain involved in direct contact with the IgE ligand and that domain one has a structural function of great importance in maintaining the integrity of the interdomain interface and, through it, the ligand-binding site.

Cited by (0)

*

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Recipient of a Union Chimique Belge Institute of Allergy traveling fellowship.

§§

Present address: Div. of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, 2601, Australia.